Sage Therapeutics Inc (SAGE)
10.78
+0.16
(+1.51%)
USD |
NASDAQ |
Jul 05, 16:00
10.77
-0.01
(-0.09%)
After-Hours: 20:00
Sage Therapeutics Net Income (Annual): -541.49M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -541.49M |
| December 31, 2022 | -532.78M |
| December 31, 2021 | -457.89M |
| December 31, 2020 | 606.07M |
| December 31, 2019 | -680.24M |
| December 31, 2018 | -372.88M |
| Date | Value |
|---|---|
| December 31, 2017 | -270.12M |
| December 31, 2016 | -158.99M |
| December 31, 2015 | -94.50M |
| December 31, 2014 | -33.81M |
| December 31, 2013 | -18.28M |
| December 31, 2012 | -9.632M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-680.24M
Minimum
2019
606.07M
Maximum
2020
-321.27M
Average
-532.78M
Median
2022
Net Income (Annual) Benchmarks
| Biogen Inc | 1.161B |
| Vanda Pharmaceuticals Inc | 2.509M |
| Ligand Pharmaceuticals Inc | 52.15M |
| ADMA Biologics Inc | -28.24M |
| Axsome Therapeutics Inc | -239.24M |